Results 221 to 230 of about 31,287 (242)

Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

European Journal of Nuclear Medicine and Molecular Imaging, 2015
Kristoff Muylle, Danielle J Vugts, Nathalie Meuleman   +2 more
exaly  

Rituximab

Reactions Weekly, 2012
openaire   +2 more sources

Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL

Annals of Oncology, 2014
V Poeschel, L Trumper
exaly  

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

Journal of Autoimmunity, 2015
Darren M Roberts, Rachel B Jones, Rona M Smith   +2 more
exaly  

Rituximab

Reactions Weekly, 2018
openaire   +2 more sources

‘Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions’

Oncogene, 2007
Benjamin Bonavida, Bonavida B
exaly  

Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney‐Transplant Patients

American Journal of Transplantation, 2010
L Lavayssière, O Cointault, M Abbal
exaly  

Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab

Autoimmunity Reviews, 2013
Ignasi Rodríguez-Pinto, Ricard Cervera, Nathalie Morel   +2 more
exaly  

Pharmacokinetics of rituximab and its clinical use: Thought for the best use?

Critical Reviews in Oncology/Hematology, 2007
Guillaume Cartron, Gilles Paintaud, Hervé Watier   +2 more
exaly  

A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function

American Journal of Transplantation, 2013
Elena G Kamburova, Irma Joosten, Luuk B Hilbrands   +2 more
exaly